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1. INTRODUCTION AND AIMS 
As a consequence of their high biological relevance, β-amino acids have gained an 
important role in medicinal and organic chemistry in the last twenty years. These structures are 
present in many natural compounds either in free form or as part of more complex molecules. 
Certain representatives such as the 5-membered carbocyclic cispentacin (isolated from the 
culture broth of Bacillus cereus) or icofungipen possess strong antifungal activities. Moreover, 
new generation peptides built from β-amino acids show well-ordered secondary structures and 
exhibit stability against proteases or peptidases; therefore, they are important molecules for 
medicinal chemistry.1-16 Since the early 1990s thanks to the effective development and 
commercial availability of well-defined Ru-based catalysts, olefin metathesis reactions have 
revolutionised the synthetic thinking. Metathesis, consequently, has become a powerful tool for 
the creation of one or more C–C double bonds. With this new method in hand, many natural 
and biologically active compounds have been prepared, which were previously challenging or 
impossible to synthesize. Besides their utilisation at the laboratory scale, olefin metathesis has 
gained industrial applications as well.17-39 
In the Institute of Pharmaceutical Chemistry at the University of Szeged, a number of 
synthetic methods were developed to access highly-functionalised cyclic β-amino acids.40-63 
Although the synthetic approaches presented in these studies cover a broad spectrum of 
chemical transformations including selective techniques, olefin metathesis reactions were not 
utilised. It has been realised, however, that the numerous types of metathesis transformations 
[ring-closing metathesis (RCM), ring-opening metathesis (ROM), ring-opening metathesis 
polymerisation (ROMP), acyclic diene metathesis polymerisation (ADMET), ene–yne 
metathesis (EYM), and cross metathesis (CM)] provide versatile protocols for the convenient 
preparation of diversely substituted β-amino acids and β-lactams. 
The present PhD work focuses on the development of stereocontrolled synthetic methods 
for the preparation of novel alkenyl-functionalised β-amino acids and β-lactams through 
ring-opening metathesis reaction and on their subsequent functionalisation via cross metathesis 
taking place in highly selective manner in some cases. The ring-opening protocol is based on 
the high ring strain of the starting bi- or tricyclic compounds, which works as a driving force 
during stereocontrolled transformations. The products sometimes were prepared in optically 
pure form through enzymatic kinetic resolution of racemic compounds with azetidinone 
framework. 
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2. LITERATURE BACKGROUND 
2.1. Background and history of metathesis reactions 
Over the last 50 years, olefin metathesis has revolutionised synthetic organic chemistry 
and became a powerful tool to create one or more C–C double bonds under mild conditions 
with good functional group tolerance. This is a catalytic process in which redistribution of        
C–C double bonds occur mediated by a transition metal–carbene complex.64 The word 
metathesis comes from the Greek 𝜇𝜖𝜏𝛼𝜃𝜖𝜎𝜄𝜁 meaning transposition and has been used for this 
kind of reaction since 1967.65-66 Metathesis reactions have gone through a long and difficult 
path to reach the present versatile form and they are not only new elements of the synthetic 
toolbar of organic chemistry, but changed the way chemists think about synthetic problems.67-75 
The metathesis story started from three seemingly unrelated observations. In the late 
1950s researchers at multiple companies reported the transformation of propylene to ethylene 
and 2-butenes in the presence of molybdenum compounds. It is interesting that in 1931 
Schenider and Fröhlich reported a very similar transformation when they heated propylene at 
752 °C without any catalyst, but their publication was ignored for a long time.76-80 The next 
discovery was made in 1960 by a group at DuPont. They submitted norbornene to 
polymerisation resulting in a highly unsaturated polymer chain instead of the expected saturated 
one.81 Finally, in 1964, during the attempted polymerisation of cyclopentene with tungsten and 
molybdenum halide catalysts, Natta et al. reported the unexpected formation of an unsaturated 
polymer.82 These serendipities served a good starting point for further research. 
In early times poorly-defined homogeneous and heterogeneous catalytic systems were 
used. These were based on transition metal compounds with strong Lewis acidic nature. Most 
functional groups did not tolerate these acids, which had many other drawbacks as well such as 
sensitivity to moisture or air. For these reasons in this time period the applicability of metathesis 
reaction was strongly limited.67 The breakthrough came when Grubbs published the first 
well-defined Ru-based catalyst, which successfully polymerised norbornene and exhibited high 
stability against oxygen and water.83 The real success for olefin metathesis comes from the wide 
range of transformations (RCM, ROMP, CM, ROM, EYM, and ADMET), which are feasible 
through this catalytic process (Fig. 1).  A further useful property is that in most of the practically 
important cases the only side-product is a volatile olefin, which significantly facilitates 
purification. However, it should be taken into consideration that during metathesis reactions 
every starting material and possible product are in equilibrium with each other.  
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Figure 1. 
2.2. Development of the olefin metathesis mechanism  
Since the late 1950s researchers have been highly interested in olefin metathesis reactions 
because it seemed to be something mysterious, because numerous observations could not be 
explained on the basis of common knowledge at that time. The chemical community had to 
wait until 1967 for the first mechanistic proposal, which came from Bradshaw and was updated 
by Calderon in the following year (Fig. 2).84-86 A four-centred pathway was assumed in which 
the interchange of the C–C double bonds takes place through a cyclobutane–metal complex 
intermediate (“pair-wise” mechanism). In 1972 Robert H. Grubbs, who had the primary role in 
the development of metathesis catalysts, also proposed a mechanism where the formation of 
the new olefin proceeds via a metallacyclopentane intermediate.87 However, at that time the 
mechanism accepted today was already known published in 1971 by Yves Chauvin and his 
student Jean-Louis Hérisson.64 Their theory, which is in agreement with all of experimental 
results, assumed the viability of a metal alkylidene (or metal carbene) complex. 88-97 In the first 
step it reacts with the olefin in a [2+2] cycloaddition (A reaction) to form the corresponding 
metallacyclobutane B. Note that [2+2] cycloadditions of alkenes are not allowed thermally, 
because of the symmetry rules.98 In the following cycloreversion step, the formation of both the 
new C–C double bond and the new carbene complex occur by the redistribution of electrons 
(see C). The new alkylidene complex D can start a new catalytic cycle again with an olefin. 
Every step of the mechanistic pathway is reversible, resulting in an equilibrium mixture. In 
2005, when the Chemistry Nobel Prize was announced, the metathesis reaction was compared 
in an animation to dance, where the participants (olefins) can exchange their partner only if they 
make a dance with the master of ceremony (catalyst) before.99 
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Figure 2. 
2.3. Evolution of metathesis catalysts 
As it was mentioned previously, ill-defined early catalytic systems had many drawbacks 
which, together with the need to understand the mechanism better, made catalyst development 
necessary.67 In general, metathesis catalysts today can be divided into two categories based on 
the central metal. Schrock catalysts possess Mo or W in the coordination centre, while the 
Grubbs catalysts have Ru. This section intends to deal only with the evolution of Grubbs 
catalysts since during our research work Ru-based catalysts were exclusively used. Thanks to 
easy handling and good functional group tolerance, Grubbs catalysts have gained considerable 
attention among organic chemists as useful tools to create one or more C–C double bonds. Their 
commercial availability enabled widespread utilisation, greatly contributing to the success of 
metathesis reactions.100-104 
The first well-defined Ru catalyst for olefin metathesis was published in 1992 by Robert 
H. Grubbs (Fig. 3).83 After some modification of the ligands, Grubbs and co-workers reported 
the next well-defined catalyst three years later what is now known as the first generation Grubbs 
catalyst.105 These two communications have been real milestones in the metathesis history since 
from this time on, metathesis reactions do not need rigorous exclusion of air and moisture, 
making them available for practically everyone. In 1999 after an intensive study of ligand effect 
in metathesis reactions, a second generation catalyst was reported by Grubbs and co-workers.  
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They have introduced a mixed catalyst where one phosphine of the parent complex was replaced 
by an aryl-substituted N-heterocyclic carbene ligand.106 While these catalysts possess superior 
activity and significantly expanded the scope of metathesis reactions, they still retained the 
beneficial properties of the first generation molecule. 
Another significant episode during the time of catalyst development was the introduction 
of chelating benzylidene ligands by Hoveyda in 1999.107 This idea has opened numerous new 
possibilities to the fine tuning of the catalysts through the modification of the stability of the 
Ru–O bond. These studies clearly showed that steric crowding around the chelating oxygen and 
an electron–withdrawing group on the benzylidene ring lead to the weakening of the OiP→Ru 
bond resulting in faster initiation.108-112 It is worth mentioning that the detailed mechanistic 
pathway of the Hoveyda catalysts was a long-standing question although the release–return 
mechanism (boomerang effect) became a widely accepted theory.113 
 
Figure 3. 
2.4. Industrial applications of the metathesis reaction 
Beside of research laboratories, olefin metathesis reactions appeared in different fields of 
industrial chemistry including the production of petrochemicals, oleochemicals, and 
polymers.33-39 It is difficult to select, which should be discussed among industrial applications, 
because of the widespread exploitation of metathesis reactions. Nevertheless, the following 
processes cannot be ignored. The Phillips Triolefin Process was originally developed for the 
production of ethylene and 2-butene by the CM reaction of propylene. Taking advantage of the 
equilibrium nature of metathesis, today this reaction is utilised in the reverse direction because 
of the high commercial demand of propylene.34 Almost 50 years before, an elegant process was 
elaborated for the manufacture of primary C11–C15 fatty alcohols in the laboratories of Shell 
Development Company. The Shell Higher Olefin Process (SHOP) consists of four main parts 
(oligomerisation, linear hydroformylation, isomerisation, and metathesis). In the last step, 
olefin metathesis is responsible for the utilisation of “nonmarketable” olefins.114  
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Last but not least, olefin metathesis has a huge impact in the field of polymer chemistry. Several 
strained cyclic and bicyclic olefins have been polymerised by ROMP. One of the best-known 
industrial products is Telene® or Metton® manufactured by the polymerisation of 
dicyclopentadiene.34 
2.5. Application of metathesis for the synthesis of natural and bioactive 
products 
Since the discovery of well-defined Ru-based catalysts, several naturally occurring and 
biologically active products were prepared where some metathesis reactions was utilised as a 
key step during the procedure.25-31 In this field Ring-Rearrangement Metathesis (RRM) is 
especially useful, because it enables the formation of highly diverse unsaturated ring systems 
in a tandem fashion.115-116 This reaction has many advantages over the usual stepwise approach, 
such as decreasing the number of steps, and minimizing the necessary reagent, solvent, and 
purification. These benefits were utilised in 1999 by Granja et al. when “taxosteroid” containing 
the same [5,3,1] bicyclic ring system as taxol was synthesised via cascade dienyne metathesis 
reaction (Fig. 4).117 RCM was applied successfully during the synthesis of the potential cancer 
drug epothilone A or the hepatitis C virus (HCV) protease inhibitor BILN 2061 to form the 
corresponding macrocycle.118-119 Chemoselectivity achievable by selecting the appropriate 
catalyst even in the case of highly-functionalised molecules is another great advantage of 
metathesis reactions.120 
 
Figure 4. 
  
7 
 
2.6. General rules for cyclisation through metathesis reaction 
Thanks to the well-defined Ru-based Grubbs catalysts, RCM reactions evolved into a 
very popular and widely used method for the construction of simple or more complex ring 
systems from the corresponding diene. The literature became enormous and excellent studies 
were published over the last two decades. A further feature that increases the value of this 
process is that not only carbocyclic compounds but also their heterocyclic counterparts can be 
prepared (Fig. 5). Basically, two factors determine the equilibrium and, therefore, the outcome 
of the RCM: entropy and enthalpy. Removal of the formed volatile ethylene, which can be 
accelerated with increasing the temperature, results in entropic gain, which facilitates both 
ring-closing and polymerisation of the diene. In order to prefer cyclisation over polymerisation, 
the use of low concentrations is a commonly applied technique. On the other hand, enthalpy 
also plays a crucial role during ring formation. Creation of thermodynamically stable 5- or 
6-membered cyclic compounds is usually readily accomplished with RCM protocol. Problems, 
however, arise when larger or strained ring systems are desired. Finally, it is worthwhile to 
mention that selection of both the appropriate catalyst and its quantity are of pivotal importance. 
Unfortunately, a universally applicable catalyst, which outperforms all others in all cases, does 
not exist, and the amount of the catalyst used strongly influences the outcome of the 
reaction.121-126 
 
Figure 5. 
2.7. Synthesis and transformations of cyclic β-amino acids through metathesis 
reaction 
Over the last two decades, olefin metathesis reactions have gained widespread application 
towards the access of cyclic β-amino acid. Modern Ru-based catalysts greatly facilitated the 
proliferation of this method, since they are applicable on densely-functionalised molecules 
leading to the formation of complex products.67 Ring-closing metathesis is a frequently applied 
key step to construct cyclic frameworks with different sizes.124 The formed C–C double bond 
affords great possibilities for further functionalisation such as epoxidation, dihydroxylation, or 
Diels–Alder reactions. This pathway requires furnishing the acyclic compounds with alkenyl 
groups to enable cyclisation. A less common approach is application of cross metathesis to form 
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appropriate acyclic precursors for subsequent cyclisation. In most cases, protocols developed 
for the construction of cyclic β-amino acids are suitable for the preparation of different ring 
sizes. Publications usually describe preparation of both 5- and 6-membered cycles using the 
same method; therefore, these syntheses were summarised separately from the construction of 
larger or condensed rings. Numerous research groups utilised metathesis reaction toward cyclic 
β-amino acids and some of the major developments are summarised below. 
2.8. Synthesis of 5- and 6-membered cyclic β-amino acids by ring-closing 
metathesis (RCM) 
Abell and Gardiner have elaborated an elegant process by RCM for the construction of 
6-membered cyclic cis and trans β2,3-amino esters substituted or unsubstituted at the α-position 
(Scheme 1).127 First, acyclic β-amino ester (±)-1 (obtained from protected allyl-glycine) was 
transformed into diene (±)-2 by stereoselective allylation. This was followed by RCM in the 
presence of Grubbs 1st generation catalyst (G1) smoothly affording trans cyclohexene 
β2,3-amino acid derivative (±)-3 with cyclohexene skeleton. Saturated derivative (±)-4 was 
easily accessible with the reduction of the C–C double bond by hydrogenation on Pd/C. 
 
Scheme 1. 
To extend the former approach, α-substituted cyclic β-amino acids (±)-7 and (±)-9 were 
synthesised (Scheme 1). The relative stereochemistry of the carboxylic and the amino functions 
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depended on the sequence of alkylation. When compound (±)-1 was first reacted with alkyl 
iodide and then with allyl bromide, the cyclisation of resulting (±)-6 afforded trans derivative 
(±)-7. However, if the alkylation sequence was changed (allylation followed by alkylation) 
compound (±)-8 was formed, which can be cyclised to cis amino acid (±)-9. Noteworthy that 
the use of optically pure 1 prepared using Evans chiral auxiliary group enables the synthesis of 
(-)-3 and (-)-4 in enantiopure form. 
The same group published an extended version of the above method for the synthesis of 
cyclic β2,3-amino acid derivatives substituted or unsubstituted at the α-position (Scheme 2).128 
This approach is suitable for the preparation of 5-, 6- and 7-membered ring systems. From 
readily accessible optically active α-amino acid building blocks such as (S)-methionine or 
(R)-allyl glycine, enantiopure 5- or 6-membered cyclic β2,3-amino acids can easily be prepared. 
The first step of the synthetic strategy towards 5-membered rings was an Arndt–Eistert carbon 
chain elongation of Cbz-protected (S)-methionine-10 to form the corresponding β-amino acid 
(-)-11, which was subsequently submitted to stereoselective allylation with allyl bromide and 
LDA in the presence of LiCl. The other alkenyl group, necessary for the cyclisation [product 
(-)-13], was formed in the next step by oxidative elimination. 
 
Scheme 2. 
Compound (-)-13 was readily transformed to 5-membered cyclic β2,3-amino acid in the 
presence of Grubbs 2nd catalyst (G2) with excellent yield. However, if the temperature was 
increased both the expected ring-closure product (+)-14 and its isomerised derivative 15 were 
formed in a 1.5:1 ratio. As it was mentioned above, this synthetic strategy is suitable for the 
preparation of α-substituted cyclic derivatives. For this purpose, compound (-)-11 was 
stereoselectively alkylated by MeI, which gave the α-methyl substituted ester as a single 
diastereomer (-)-16 (Scheme 3). 
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Diastereoselective allylation of compound (-)-16 gave product (-)-17, which was transformed 
by oxidative elimination to acyclic β-amino acid derivatives (-)-18 with two alkenyl 
side-chains. 
 
Scheme 3. 
To avoid isomerisation experienced before, RCM of compound (-)-18 was executed at 
room temperature with G2 catalyst to afford unsaturated 5-membered α-methyl substituted 
cyclic β2,3-amino ester (+)-19. The authors also improved their method towards enantiopure 
6-membered cyclic β-amino esters by finding an alternative route to prepare starting compound 
1. Asymmetric synthesis was used to prepare Cbz-protected (R)-allyl glycine, which was 
submitted to Arndt–Eistert homologation resulting in optically pure (+)-1. Following the steps 
of Scheme 1 led to (-)-3 and (-)-4. 
Chippindale and co-workers developed a versatile method enabling the stereoselective 
synthesis of 5-membered cyclic β2,3- and β3-amino acids and 6-membered cyclic β3-amino 
acids.129 First, compounds (+)-22a,b were synthesised by conjugate addition of lithium 
(S)-allyl(1-phenylethyl)amide 20 to α,β-unstaurated esters 21a,b with high d.e. (Scheme 4). 
RCM reaction of (+)-22a,b resulted in N-heterocyclic β3-amino acid derivatives (-)-23a and 
(+)-23b, which were transformed into free amino acids (+)-24a,b. 
 
Scheme 4. 
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In order to synthesize cyclic β2,3-amino acids, allylation of intermediate (+)-22a was 
performed affording an inseparable mixture of anti and syn diastereomers 25 (Scheme 5). 
However, the related secondary amines obtained through N-deallylation of compound 25 with 
Wilkinson catalyst were separable by column chromatography and the major (anti) 
diastereomer (-)-26 was isolated with >95% d.e. and in 77% yield. Based on earlier experience, 
the amine function was transformed to carbamate in order to avoid chelate formation, which 
greatly reduces the activity of the Grubbs catalyst. Cyclisation of (-)-27 by RCM led to cyclic 
β2,3-amino acid derivative (+)-28, which was subsequently deprotected to afford transpentacin 
(+)-29. 
 
Scheme 5. 
Davis and Theddu elaborated a general methodology for the asymmetric synthesis of 
cyclic cis-β-amino Weinreb amides, which are easily convertible in two steps to cyclic cis 
β2,3-amino acid derivatives.130 As depicted in Scheme 6, optically pure acyclic dienes (+)-32a,b 
were synthesised with varied alkenyl chains by the conjugate addition of unsaturated prochiral 
Weinreb amide 31a,b (enolates generated by LDA) to chiral sulfinimine (S)-(+)-30 with high 
>99:1 d.r. Oxidation of compounds (+)-32a,b at sulfur resulted in tosyl-protected compounds 
(-)-33a,b. RCM of compounds (+)-32a,b and (-)-33a,b with G2 catalyst gave the expected 
cyclic β-amino Weinreb amides (+)-34a,b and (+)-35a,b, respectively. The possibility of 
liberating the carboxyl group was studied in details in the case of 5-membered derivatives 
(+)-34a and (+)-35a. Both compounds decomposed during hydrolysis; however, in the case of 
Weinreb amide (+)-34a, saturation of the ring followed by hydrolysis smoothly afforded 
aminocarboxylic acid (-)-36. 
12 
 
 
 
Scheme 6. 
The strategy discussed above in detail is applicable for the asymmetric synthesis of 
7-membered cyclic cis-β-amino Weinreb amides too. It is worth mentioning that in addition to 
β-amino acids, several valuable molecules are achievable via Weinreb amides, such as ketones, 
aldehydes, β-ketoesters, and β-ketophosponates. 
A stereoselective route towards cyclic β2,3-amino acids was developed by Perlmutter et 
al. in which the bonds formed by nucleophilic addition (AN) were transformed by ring closure 
(RC) (NARC protocol).131 This is a frequently applied method for the synthesis of hetero- and 
carbocyclic compounds.132 A key step of the procedure is the diastereoselective condensation 
between pyridyl thioesters 37a,b and optically pure imine (R)-38 (Scheme 7). The reaction 
provided a mixture of diastereomers [(+)-39 is the major and 40 the minor product], which were 
readily separable by flash chromatography. Attempted ring closure of (+)-39a,b to form 
bicyclic β-lactams were unsuccessful because of the evolving ring strain. To avoid this synthetic 
problem the 4-membered heterocyclic rings were opened to get acyclic dienes (+)-41a,b, which 
easily underwent RCM with G1 catalyst. Hydrogenation of the double bond then hydrolysis 
with HCl afforded optically pure 5- and 6-membered saturated cyclic β-amino acid 
hydrochlorides (+)-29 and (+)-43. 
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Scheme 7. 
2.9. Synthesis of 5- and 6-membered cyclic β-amino acids by cross 
metathesis (CM) 
While several open-chain dienes have been successfully transformed by RCM, only a few 
examples were reported where CM was utilised toward cyclic β-amino acids. In these cases, 
the role of metathesis was the preparation of appropriate acyclic precursors, which were 
cyclised by intramolecular addition or condensation. In one of these examples, Fustero and 
co-workers recently reported a diastereodivergent synthesis of enantiomerically pure 
fluorinated homoproline derivatives (cyclic β3-amino acids) with three chiral centers.133 As 
shown in Scheme 8, deprotonation of sulfoxide (S)-44 at the benzylic position led to the 
corresponding carbanion. Addition of the latter to fluorine-containing aldimine 45 yielded 
amine 46 with high diastereoselectivities. Cross metathesis performed with ethyl acrylate 47 in 
the presence of Hoveyda-Grubbs 2nd catalyst (HG2) gave 48 as a mixture of E/Z diastereomers. 
Cyclisation via intramolecular aza-Michael reaction can result in two epimers of 49 with 
relative syn or anti arrangement of the fluorinated alkyl group and the CH2CO2Et moiety.  
 
Scheme 8. 
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Diastereoselectivity depended on the reaction conditions: base-promoted cyclisation gave the 
anti epimer as the main product, while treatment with Lewis acidic BF3·OEt2 afforded mostly 
the syn epimer because of the formation of a chelate ring involving the ester carbonyl, the 
sulfoxide and the nitrogen atom (Scheme 9). Removal of the chiral auxiliary was achieved in 
the final step using Raney Ni catalyst in THF to give homoproline derivatives 50. 
 
Scheme 9. 
The second example was also elaborated by the same research group. They successfully 
conducted racemic and asymmetric syntheses of difluorinated 5-, 6-, and 7-membered (see 
later) cis cyclic β2,3-amino acids through CM (Scheme 10).134 In the first step, imidoyl chlorides 
52a,b were prepared from the corresponding 2,2-difluorinated carboxylic acids 51a,b. 
Cross-coupling reaction between these imidoyl chlorides and ethyl acrylate 47 gave the 
expected acyclic compounds 53a,b. This is a remarkable achievement as the first reported case 
of using the G2 catalyst in the reaction of imidoyl chlorides. 
 
Scheme 10. 
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Chemoselective hydrogenation of the C–C double bond and subsequent Dieckmann 
condensation with LDA at -78 °C resulted in the formation of cyclic enamino compounds 54a,b. 
After several experiments, chemo- and stereoselective reduction was accomplished to furnish 
the final product (±)-55a,b with cis configuration. In the final step the method was extended to 
the preparation of enantiomerically pure compounds. For this purpose, (+)-8-phenylmenthol 
acrylate was coupled with imidoyl chloride 52a to afford the optically pure analogue of 
compound 53a, which was further transformed similarly to the racemic counterpart (53a). 
2.10. Synthesis of β-amino acids with larger ring system by ring-closing 
metathesis (RCM) 
Construction of larger rings has challenged organic chemists for a long time; however, 
several techniques are available in the synthetic toolbar today.135 RCM opened up new 
possibilities for the syntheses of medium rings to macrocycles, because low substrate 
concentrations prefer ring closing over polymerisation even in the case of these challenging 
ring systems.124 Among several compounds, β-amino acid derivatives were also prepared in this 
manner. Of the methods described in Sections 2.8 and 2.9, four strategies were applicable for 
the construction of larger ring systems. 
The method developed by Gardiner and co-workers, where 5- and 6-membered cyclic 
β2,3-amino esters were prepared from easily accessible α-amino acids building blocks, was 
extended to create 7-membered rings (Scheme 11).128 Acyclic precursor (-)-57, synthesised 
from (S)-serine-56 in multiple steps similar to (-)-13, was cyclised by G2 catalyst then 
hydrogenated on Pd-carbon to give the target compound (+)-59. 
 
Scheme 11. 
Diastereoselective conjugate addition of lithium (S)-N-allyl-N-α-methylbenzylamide 20 
to α,β-unsaturated ester 21a developed by Chippindale and co-workers is also applicable for 
the preparation of larger ring.129 As depicted in Scheme 12 compound (-)-60, which was 
synthesised in a similar fashion to (-)-27 (see section 2.8 for the detailed pathway), was treated 
with G1 catalyst to afford 7-membered unsaturated cyclic molecule (+)-61. 
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Scheme 12. 
Davis and Theddu successfully applied their approach (detailed in Scheme 6) for the 
preparation of a 7-membered ring by subjecting prochiral Weinreb amide 62 to conjugate 
addition with acrolein-derived sulfinimine (S)-(+)-30.130 Precursor (+)-63 thus formed was 
easily cyclised with G2 catalyst to 7-membered cyclic β-amino acid derivative (+)-64 
(Scheme 13). 
 
Scheme 13. 
The method developed by Fustero and co-workers synthetize, where imidoyl chlorides 
obtained through CM and subsequent reduction were subjected to Dieckmann condensation, is 
also capable of furnishing a 7-membered ring system.134 As shown in Scheme 14, cyclisation 
of 65, in this case, resulted in compound 66 as a tautomeric mixture with a 3:2 ratio. In the final 
step, chemo- and stereoselective reduction afforded fluorinated cis-2-aminocycloheptane 
carboxylic acid derivative (±)-67. 
 
Scheme 14. 
In 2003, the Fustero’s group published a study where 7-membered cycles such as 
compounds (±)-71 and (±)-73 were synthesised exclusively through RCM (Scheme 15).136 In 
this approach fluorinated imidoyl chloride 52a prepared earlier (see Scheme 10) was submitted 
to condensation with enolate of 4-pentenoic acid ethyl ester 68 to yield β-imino ester (±)-69. 
Next, cyclisation was executed with both first- and second-generation Grubbs catalysts where 
the latter afforded a better performance. The resulting tautomeric mixture 70, in which the imino 
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form dominated, was reduced with NaCNBH3 in a diastereoselective fashion to afford 
fluorinated cis β-amino acid derivative (±)-71 with 7-membered ring as the sole product. 
Furthermore, the synthesis of trans derivative (±)-73 could also be accomplished. Namely, 
reduction of (±)-69 with NaCNBH3 gave a 1:1 mixture of syn and anti diastereomeric 
open-chain β-amino esters (±)-72a and (±)-72b, and this mixture gave the desired compound 
through RCM. 
 
Scheme 15. 
For the preparation of β-turn mimetics, Ohkubo and co-workers developed a general 
procedure towards the exclusive synthesis of larger 7-, 8-, and 9-membered cyclic β2-amino 
acid derivatives via RCM (Scheme 16).137 The acyclic dienes were prepared in three 
consecutive steps from readily available aliphatic amines where the alkenyl chain length 
predetermined ring sizes during cyclisation. β-Amino ester skeletons were formed by conjugate 
addition of amines 74a-c to ethyl acrylate 47. Subsequent N-protection followed by allylation 
at the α-position resulted in the corresponding precursors (±)-76a-c. In the case of (±)-76a and 
(±)-76b, cyclisation smoothly afforded the desired 7- and 8-membered cycloalkene derivatives 
(±)-77a and (±)-77b, respectively. During the cyclisation of (±)-76c, because of olefin bond 
isomerisation of the starting material, (±)-77c and (±)-77b were formed together in a 4:1 ratio. 
Saturated cyclic β2-amino acid derivatives (±)-78a-c were synthesised by reduction of the C–C 
double bonds. By slightly modifying the synthetic route discussed above, the authors were also 
able to prepare N-Boc protected 7- and 8-membered cyclic β2-amino acids in enantiopure form. 
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Scheme 16. 
2.11. Synthesis of β-amino acids with condensed ring systems by 
ring-rearrangement metathesis (RRM) 
In the following short section, the usefulness of domino and tandem metathesis reactions 
in the synthesis of β-amino acid derivatives with condensed ring will be exemplified. These 
transformations allow the rapid and safe syntheses of highly diverse fused carbo- or 
heterocyclic ring systems through the rearrangement of the C–C double bonds. A frequently 
applied sequence in these cases is the intramolecular ring-opening/ring-closing protocol. 
Thanks to their high ring strain, bridged bicyclic frameworks such as norbornene and 
oxanorbornene provide a great possibility toward condensed 5- or 6-membered carbo- or 
heterocyclic systems. 115-116 
Winkler et al. utilised the benefits of the oxanorbornene framework for the syntheses of 
novel tri- and pentaheterocyclic ring systems via tandem metathesis.138 First, metathesis 
substrates were prepared from bicyclic oxanorbornene amino ester 79 by changing the methyl 
ester to allyl ester 80 followed by N-allylation to give 81 or N-allylation to 82 and subsequent 
creation of an N-allylamide moiety (product 83, Scheme 17). Ring-opening metathesis of the 
strained oxabicyclo ring of 81 afforded reactive intermediate 84 with four terminal alkene 
functions. It immediately reacted further by RCM to form condensed tricyclic β-amino acid 
derivative 85. Analogous tandem metathesis of precursor 83 gave compound 86 a lactam 
analogue of 85. 
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Scheme 17. 
Pentacyclic product 91 can be synthesised in a similar fashion, although it requires a very 
high catalyst loading during the ROM/RCM step (Scheme 18). In this case, metathesis 
precursor 89 was prepared by reductive amination of aldehyde 88 with O-allylated amino ester 
87 prepared previously followed by N-tosylation. An important role of the tosyl group is to 
influence the rotational equilibrium of 90 ensuring the presence of the cis rotamer needed for 
the RCM step. 
 
Scheme 18. 
Nadany and Mckendrick applied a similar pathway towards constrained bicyclic β-amino 
acid derivatives. However, in these cases, only a single ring closure occurred (Scheme 19).139 
To avoid the chelate formation with participation of the catalyst, carbonyl oxygen and the 
nitrogen atom, trans N-tosylated β-amino esters were utilised as starting materials in all cases. 
First, compound (±)-92 was reacted with allyl bromide to produce metathesis substrate (±)-93. 
Next, RRM of trans β-amino ester (±)-93 in the presence of ethylene and G1 catalyst readily 
afforded the desired nitrogen-containing condensed heterocycle (±)-94 in tandem fashion. 
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Domino metathesis reaction of the previously prepared homologous (±)-96, (±)-98, (±)-100, 
and (±)-102 allows the formation, respectively, of 5,6-fused (±)-97, 5,7-fused (±)-99, and 
(±)-103, and 5,8-fused bicyclic β-amino acid esters (±)-101. 
 
Scheme 19. 
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3. RESULTS AND DISCUSSION 
3.1. Stereocontrolled one-step synthesis of difunctionalised cispentacin and 
transpentacin derivatives through ring-opening metathesis (ROM) of 
norbornene β-amino acids 
Our synthetic strategy towards difunctionalised cispentacin and transpentacin derivatives 
was based on the ROM reactions of constrained unsaturated bi- and tricyclic ring systems driven 
by the release of their high ring strain. For this purpose, norbornene β-amino esters were 
excellent candidates. In order to increase the number of achievable cispentacin stereoisomers, 
some stereoisomeric bicyclic precursors were synthesised. In the first step metathesis substrate 
compound (±)-107 was prepared by the well-known pathway from readily available starting 
materials. The synthetic strategy started with the stereoselective addition of chlorosulfonyl 
isocyanate (CSI) to norbornadiene 104 in dry Et2O followed by chlorosulfonamide hydrolysis 
with Na2SO3 resulting exclusively in exo-lactam (±)-105 as depicted in Scheme 20.140 
 
Scheme 20. 
In the next step, the 4-membered heterocycle was opened by HCl/EtOH and subsequent 
benzoyl protection of the amino group gave the corresponding unsaturated bicyclic target  
compound (±)-107.55 diendo-Norbornene β-amino ester (±)-112 was achievable in a slightly 
different route as shown in Scheme 21. First, endo-anhydride (±)-110 was prepared via      
Diels–Alder reaction between cyclopentadiene 108 and maleic anhydride 109. Next, 
ring-opening reaction of the heterocycle with NH3 followed by Hoffmann degradation smoothly 
afforded bicyclic β-amino acid (±)-111.139 Finally, the carboxyl function was esterified with 
SOCl2/EtOH and subsequent benzoylation gave desired metathesis substrate 
diendo-norbornene β-amino ester (±)-112.56 
 
Scheme 21. 
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Next, epimerised derivatives of (±)-107 and (±)-112 were prepared by their treatment 
with NaOEt in EtOH. The reaction afforded the so-called endo-exo (±)-113 and exo-endo 
(±)-114 compounds in which the ester and the amide group are trans to each other. With the 
four bicyclic metathesis substrates in hand [(±)-107, (±)-112, (±)-113, and (±)-114], their 
ring-opening metathesis reaction was studied toward the preparation of functionalised 
cispentacin derivatives. It was found that racemic 3,5-divinylated amino ester stereoisomers 
(±)-115, (±)-116, (±)-117, and (±)-118, which differ in the relative configuration of the C-1 
and/or C-2 atom, were readily accessible through ROM of the corresponding starting bicyclic 
compounds in the presence of ethylene and metathesis catalyst (Scheme 22). 
 
Scheme 22. 
Metathesis reactions were performed systematically in anhydrous CH2Cl2 with ethylene 
under argon atmosphere in the presence of a metathesis catalysts (G1, G2, HG1, or HG2) for 2 
h. In the case of diexo- and diendo-β-amino ester metathesis substrates (±)-107 and (±)-112, 
clear general correlation between the yield and the used catalyst was not found, although HG2, 
in both cases, was slightly more effective than the other catalysts. Notably, however, yields in 
the case of endo-exo (±)-113 and exo-endo (±)-114 derivatives found with first generation 
catalysts were more than two times higher than those by second generation ones (see Table 1). 
The best yields (80% and 68%) were achieved also with endo-exo (±)-113 and exo-endo (±)-114 
compounds. Lower yields found with diexo and diendo derivatives (±)-107 and (±)-112 may be 
explained by chelation of the catalyst. Specifically, the cis arrangement of the amide and ester 
groups in these substrates enable their simultaneous coordination to the Ru centre, which greatly 
reduces the efficiency of the catalyst. It is worth mentioning that the bicyclic starting materials 
have four asymmetric centres, and since these atoms are unaffected during the transformation, 
the chiral information is transferred to the final products. Notably, compound (±)-115 was 
synthesised earlier from the same starting material (±)-107 on another synthetic route by our 
research group in a 30% overall yield.55  
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The present method not only afforded significantly higher yields and saved a number of 
steps, but avoided the use of highly toxic chemicals such as OsO4. Moreover, all-cis divinylated 
amino ester (±)-116 could not be synthesised by the previously mentioned method because of 
base-induced epimerisation.56 
Table 1. Isolated yields for (±)-115, (±)-116, (±)-117, and (±)-118 in ROM reactions with various catalysts. 
Catalyst 
G1 G2 HG1 HG2 
Catalyst 
G1 G2 HG1 HG2 
Products Products 
 
37% 33% 38% 41% 
 
6% 26% 29% 31% 
(±)-115 (±)-116 
 
46% 20% 80% 28% 
 
68% 29% 45% 16% 
(±)-117 (±)-118 
 
A possible pathway for 3,5-divinylated final products is depicted in Figure 6. Because of 
the high concentration of ethylene, the first step of the mechanism is the formation of reactive 
methylidene complex Ru-I from the so-called pre-catalyst (HG2) by ligand exchange 
(metathesis reaction). In the next step, [2+2] cycloaddition occurs between norbornene β-amino 
acid derivatives and newly formed carbene Ru-I affording the corresponding 
metallacyclobutane Ru-II condensed with the bicyclic skeleton. Opening of the strained 
tricyclic framework takes place in the cycloreversion step by redistribution of the electrons 
forming new alkylidene complex Ru-III. Finally, another cycloaddition reaction of newly 
formed cyclic 5-membered Ru-containing β-amino ester Ru-III with ethylene takes place 
followed by cycloreversion resulting in the desired ring-opened product. The original 
Ru-methylidene complex Ru-I is reformed in this step and it can start the catalytic cycle again. 
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Figure 6. 
The above detailed synthetic approach was extended to the preparation of optically pure 
target substances (+)-115 and (-)-117 (Scheme 23). First, optically active β-lactam (+)-105 was 
prepared by lipolase-catalysed enantioselective enzymatic ring-opening of racemic azetidinone 
(±)-105.141 Next, metathesis precursor (+)-107 was synthesised in an enantiomer-enriched form 
via ethanolysis followed by benzoylation. Similar to the racemates, compound (+)-107 was 
submitted to epimerisation by NaOEt in EtOH to afford endo-exo-β-amino ester derivative 
(-)-113 in good yield. Finally, ROM reactions with HG1 catalyst with ethylene under argon 
atmosphere were executed to obtain divinylated cispentacin and transpentacin compounds 
(+)-115 and (-)-117. The e.r. of optically active esters (+)-115 and (-)-117 were determined by 
chiral HPLC analysis and found to be 95:5 in both cases. 
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Scheme 23. 
In view of the relevance of oxygen-containing cyclic β-amino acids, the stereocontrolled 
one-step method applied earlier was extended toward divinylated tetrahydrofuran β-amino 
esters as depicted in Scheme 24.2 Thus, oxanorbornene amino ester (±)-122 was prepared in 
two steps from the corresponding diexo-β-amino acid hydrochloride salt (±)-120 similar to 
compound (±)-112. Epimerisation of (±)-122 with NaOEt in EtOH at 20 °C gave endo-exo 
derivative (±)-123 in moderate yield. The synthesis of novel divinylated tetrahydrofuran 
β-amino esters (±)-124 and (±)-125 was achieved in good yields from the corresponding 
bicyclic starting materials (±)-122 and (±)-123 in ROM reaction with the conservation of the 
four stereogenic centres. The metathesis reactions were performed in dry CH2Cl2 under 
ethylene and argon atmosphere in the presence of HG1 catalyst (Scheme 24).  
 
Scheme 24. 
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3.2. Stereocontrolled one-step synthesis of difunctionalised azetidinones and 
β-amino acid derivatives from condensed ring β-lactams by ring-opening 
metathesis (ROM) 
Novel functionalised azetidin-2-ones and β-amino acid derivatives were synthesised 
according to our earlier strategy. The driving force of these reactions is the formation of 
thermodynamically more stable molecules, which have lower ring strain than the bi- or tricyclic 
starting materials.115-116 During these ring-opening processes mediated by Ru–alkylidene 
complexes, epimerisation was not observed, that is the stereochemistry of the starting β-lactams 
was conserved and determined the configuration of the chiral centres in the end-products. In 
the first step, tricyclic β-lactam (±)-105 was synthesised by the well-known method, via the 
addition of CSI to norbornadiene 104 in dry Et2O at 0 °C, followed by chlorosulfonamide 
hydrolysis with Na2SO3 (Scheme 25).2 
 
Scheme 25. Syntheses of divinylated cispentacin derivatives (±)-127 and (±)-128. Yields of (±)-126 G1: 80%; 
G2: 5%; HG1: 70%; and HG2: 10%. 
Resulting diexo-β-lactam (±)-105 was subjected to ROM reaction in the presence of 
various commercially available first and second generation Ru-based catalysts (G1, G2, HG1, 
and HG2) with ethylene under argon atmosphere with stirring in dry CH2Cl2 at 20 °C. 
Divinyl-substituted β-lactam (±)-126 was formed in high yields with the first generation 
catalysts, while second generation catalysts preferred the formation of polymeric products. In 
the final step, racemic cispentacin derivatives (±)-127 and (±)-128 containing valuable olefinic 
bonds were accessed through opening of the 4-membered heterocycle. Thus, 
norbornadiene-derived β-lactam (±)-126 was subjected to hydrolysis or ethanolysis in a 
stereocontrolled fashion to afford the corresponding cyclic 5-membered β2,3-amino acid (±)-127 
or β2,3-amino ester (±)-128 as hydrochloride salts in good to excellent yields (Scheme 25). 
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The above ring-opening metathesis protocol was extended to the stereocontrolled 
syntheses of monocyclic β-lactams with terminal olefin moiety. The synthesis was started with 
the preparation of the corresponding bicyclic azetidinone framework (±)-130 in two steps from 
readily available starting materials. 1,5-Cyclooctadiene 129 was reacted with CSI in dry CH2Cl2 
at 0 °C, then hydrolysis with Na2SO3 gave 1,5-cyclooctadiene-derived β-lactam (±)-130 
(Scheme 26). 
 
Scheme 26. 
Racemic monocyclic azetidinone (±)-131 with alkenyl moieties at the end of the alkyl 
chains was accessed through metathesis in dry CH2Cl2 at 20 °C. We have tested again first and 
second generation Ru-based catalysts (see Table 2) with results strikingly similar to those found 
with norbornene β-lactam (±)-105. G1 and HG1 catalysts performed well in the ring-opening 
reaction, while G2 and HG2 was too reactive inducing mainly polymerisation resulting in low 
yields of (±)-131. Finally, treatment of compound (±)-131 with HCl/H2O at 0 °C gave the 
corresponding open-chain β-amino acid (±)-132 with the carboxyl and amine functions in anti 
arrangement. Ethanolysis, in turn, gave open chain β-amino ester (±)-133 with the same 
stereochemistry in a yield of 78%. 
Table 2. Isolated yields for (±)-131 and (±)-136 in ROM reactions with various catalysts. 
Catalyst 
G1 G2 HG1 HG2 
Catalyst 
G1 G2 HG1 HG2 
Product Product 
 
75% 7% 74% 17% 
 
60% 25% 67% 26% 
(±)-131 (±)-136 
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Following our strategy, after the successful ROM in the case of compound (±)-130, it 
seemed a logical step to prepare 1,3-cyclooctadiene-derived bicyclic β-lactam (±)-135 a 
regioisomer of compound (±)-130 (Scheme 27). For this purpose, 1,3-cyclooctadiene 134 was 
reacted with CSI using the well-known pathway to afford the desired metathesis substrate 
(±)-135 with high ring strain. During the ring-opening protocol, first generation catalysts proved 
to be beneficial again, although ring-opening product (±)-136 was also isolated in modest but 
acceptable yields in the presence of G2 and HG2 in this case (see Table 2). 
 
Scheme 27. 
In the final step, open chain β-amino acid (±)-137 and β-amino ester (±)-138 bearing 
valuable olefinic bonds were prepared. 4-Membered heterocycle (±)-136 was opened by H2O 
or EtOH under protic conditions and gave the expected products in excellent yields in both 
cases. Similar to previous experiences, when compound (±)-136 underwent hydrolysis or 
ethanolysis, configuration of the two asymmetric centres left unaffected and afforded anti 
arrangement for the carboxyl and amino hydrochloride groups, as depicted in Scheme 27. 
However, besides successful ring-opening metathesis reactions, we have encountered 
difficulties in some cases (Scheme 28). Attempted ring-opening transformations of 
cyclopentadiene- or cyclohexadiene-derived β-lactams (±)-139, (±)-141, and (±)-143, which 
have less ring strain, did not furnish the corresponding monocyclic products (±)-140, (±)-142, 
and (±)-144. Unfortunately, all metathesis reactions performed in a variety of solvents (CH2Cl2, 
toluene) at room temperature or under reflux with all catalysts (G1, G2, HG1, and HG2) failed 
and only the starting materials were detected by TLC monitoring. This may be accounted for 
by the shift of the ring-opening/ring-closing equilibrium towards recyclisation under metathesis 
conditions.  
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Obviously ring-closing reactions of (±)-126, (±)-131, and (±)-136 are less favoured 
because of evolving ring strain. Furthermore, the distance between the newly formed terminal 
alkene moieties further reduces the possibility for the ring closing reaction in the case of 
cyclooctadiene-derived compounds (±)-131 and (±)-136.124  
 
Scheme 28. 
3.3. Carbon–carbon double bond functionalisation of β-amino acid 
derivatives and β-lactams with α,β-unsaturated carbonyl compounds 
through cross metathesis (CM) 
Cross metathesis is a widely applied method for the functionalisation of C–C double 
bonds even in more complex frameworks.142 The reaction can proceed in a chemoselective 
manner and it is usually E-selective.120 Because of the advantages of metathesis 
transformations, we planned the functionalisation of terminal alkene moieties of the 
corresponding β-lactams or β-amino acid derivatives synthesised previously through cross 
metathesis reactions. For this purpose, α,β-unsaturated carbonyl compounds were used as 
electron-deficient olefins in the presence of HG2 catalyst. According to the literature, this is an 
effective cross metathesis protocol.142 The two terminal C–C double bonds on the ring-opened 
products were coupled with methyl acrylate 145 and methyl vinyl ketone 148. 
First, divinylated transpentacin (±)-117 (derived from diexo-norbornane β-amino ester 
(±)-107 by epimerisation followed by ROM) was reacted with methyl acrylate 145 in the 
presence of HG2 catalyst in dry CH2Cl2 at reflux temperature. After the chromatographic 
separation from the undesired polymeric material, dicoupled product (±)-146 was isolated in 
51% yield (Scheme 29). Importantly, cross metathesis reactions were performed with both first 
generation Grubbs catalysts, but the desired target compound formed only in trace amounts 
(monitored by TLC).  
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After the successful cross-coupling reaction of compound (±)-117, all-cis divinylated 
β-amino ester (±)-116 was subjected to cross metathesis with methyl acrylate 145 in the 
presence of HG2 catalyst. Cispentacin derivative (±)-147 with three ester functions was 
accessed analogously to (±)-146 in good yield, without epimerisation of the stereogenic centres. 
It is important to note that compound (±)-147 was identical to the material prepared earlier on 
a different synthetic pathway. It may be concluded that the CM reaction proceeded under 
stereocontroll with E selectivity, that is the configuration of the newly created C–C double 
bonds in (±)-146 and (±)-147 also have E geometry.56 
 
Scheme 29. 
Since cross metathesis reactions worked well in the case of cispentacin derivatives 
(±)-116 and (±)-117, we expanded the scope of the coupling reaction to β-lactams. Besides of 
methyl acrylate 145, the terminal alkene moieties were transformed with methyl vinyl ketone 
148 as well in these cases. First, bicyclic β-lactam (±)-126 (derived from exo-lactam (±)-105 
by ROM) was subjected to coupling reactions with α,β-unsaturated carbonyl compounds 145 
and 148 in the presence of HG2 catalyst (Scheme 30). In both cases, after chromatographic 
purification, cross metathesis products (±)-149 and (±)-150 with E geometry (high J values, in 
accordance with earlier literature data) were isolated in moderate to good yields. Cross 
metathesis reactions were performed in anhydrous solvents such as CH2Cl2 or toluene with the 
former giving higher yields in both cases (see Table 3). 
 
Scheme 30. 
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Table 3. Isolated yields for (±)-149 and (±)-150 in CM reactions with HG2 catalyst in different solvents. 
Solvent 
CH2Cl2 toluene 
Solvent 
CH2Cl2 toluene 
Product Product 
(±)-149 
53% 18% 
(±)-150 
88% 63% 
 
The well-established cross metathesis protocol for the synthesis of highly-functionalised 
bicyclic β-lactams was expanded to monocyclic unsaturated β-lactam derivatives. 
Ring-opening product (±)-131 prepared previously was coupled with methyl acrylate 145 and 
methyl vinyl ketone 148 analogously to bicyclic β-lactam (±)-126 in the presence of HG2 
catalyst as depicted in Scheme 31. Coupling reactions smoothly afforded the expected final 
products (±)-151 and (±)-152 with E geometry in good yields (see Table 4) similar to the 
formation of products (±)-149 and (±)-150 synthesised previously. 
 
Scheme 31. 
 
Table 4. Isolated yields for (±)-151 and (±)-152 in CM reactions with HG2 catalyst in different solvents. 
Solvent 
CH2Cl2 toluene 
Solvent 
CH2Cl2 toluene 
Product Product 
 
68% 55% 
 
48% 70% 
(±)-151 (±)-152 
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Finally, β-lactam derivative (±)-136 [a regioisomer of (±)-131] underwent cross 
metathesis reactions with the previously used electron-deficient olefins 145 and 148. Coupling 
reactions were carried out in dry toluene or CH2Cl2 at reflux temperature in the presence of 
HG2 catalyst (Scheme 32). Di-ester β-lactam (±)-153 was isolated in 73% yield when the 
reaction was performed in toluene, while in the case of its ketone counterpart (±)-154 the use 
of CH2Cl2 as solvent resulted in higher yield (see Table 5). 
 
Scheme 32. 
 
Table 5. Isolated yields for (±)-153 and (±)-154 in CM reactions with HG2 catalyst in various solvents. 
Solvent 
CH2Cl2 toluene 
Solvent 
CH2Cl2 toluene 
Product Product 
 
63% 73% 
 
70% 56% 
(±)-153 (±)-154 
However, it is important to note, that product selectivity during CM reactions is not 
always predictable, because it is often complicated to determine, which olefin reacts selectively. 
To solve this problem, Chatterjee et al. compiled a table containing different types of olefins 
with the appropriate catalysts.142 With this new approach in hand, high selectivity is achievable 
by using the appropriate reagents during the coupling reactions. In their studies the olefins were 
categorised in four (+1) types based i) on the susceptibility of the starting materials to form 
homodimers via CM and ii) on the ability of the coupled product toward secondary metathesis 
reactions. The first group includes olefins, which are able to undergo rapid homodimerisation 
and the product homodimers possess the same reactivity towards subsequent metathesis 
reactions as their parent olefins. 
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Type II group consists of olefins, which homodimerise slowly and their homodimers are 
sparingly consumed in secondary coupling reactions. Type III olefins lack the ability to form 
homodimers but are still able to perform CM reactions with Type I or Type II olefins. Type IV 
alkenes cannot react in CM reactions and they have no effect on the catalyst activity. Finally, 
the +1 category consists of alkenes, which inhibit catalyst activity. 
The study determines that selective CM reaction can be achieved by selecting the 
appropriate olefins from different types without using large stoichiometric excess of one 
compound. In our case, the reagents (α,β-unsaturated carbonyl compounds) are categorised as 
Type II olefins, while the substrates in the case of cispentacin and transpentacin derivatives 
[(±)-115, (±)-116, (±)-117, and (±)-118] belong to Type III based on our experimental results 
(homodimer product was not formed but reacted selectively with Type II olefins). Monocyclic 
unsaturated β-lactam (±)-131 (terminal olefin) is categorised as Type I alkene. In contrast, the 
classification is not straightforward for (±)-136 because of the different alkenyl moieties: the 
molecule contains both a terminal alkene part and a tertiary allylic position. Despite 
complications arising from the classification, CM products were isolated in all cases with 
moderate to good yields (Table 3, 4, 5 and Scheme 29). However, it is worthwhile to mention 
that, large stoichiometric excess of acrylate or ketone were used in the coupling reaction, which 
in itself increases selectivity. 
 A possible mechanism for the 3,5-dicoupled cispentacin derivative is depicted in Figure 
7.  Because of the high concentration of methyl acrylate 145 in the first step, Ru-containing 
complex Ru-V was formed by ligand exchange (metathesis reaction) with pre-catalyst HG2. 
Next, [2+2] cycloaddition occurs between the newly-formed carbene Ru-V and 3,5-divinylated 
cispentacin derivatives, which leads to the corresponding metallacyclobutane intermediate 
Ru-VI. Formation of the monocoupled product and the Ru-containing methylidene complex 
Ru-I by redistribution of the electrons take place in the cycloreversion step. The other vinyl 
group on the monocoupled 5-membered cyclic β-amino ester can be functionalised again with 
a further methyl acrylate 145 (in carbene form Ru-V) via metathesis reaction. First, 
cycloaddition occurs between newly formed mono-metathesised β-amino ester and Ru-V 
affording the corresponding metallacyclobutane Ru-VII. Formation of the desired dicoupled 
product takes place in the cycloreversion step by redistribution of the electrons. Finally, the 
reaction of the newly-formed Ru-based methylidene complex Ru-I with methyl acrylate 145 
reproduces Ru-alkylidene Ru-V which starts the catalytic cycle from the beginning. 
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Figure 7. 
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3.4. Syntheses of functionalised β-amino acid derivatives and β-lactams 
through chemoselective cross metathesis (CM) 
Chemoselectivity was observed in the field of metathesis reactions (RCM, CM, and 
EYM) in several cases. It can originate from multiple factors, including the choice of catalyst , 
since the outcome of these reactions is often catalyst dependent. Steric or electronic deactivation 
of one of the C–C double bonds is also capable of inducing chemoselectivity.120 Furthermore, 
several studies reported plausible hydrogen bond interaction in the pre-assembly phase between 
the catalyst halogen ligand and the substrate hydrogen atom, which favors the selective 
transformation of a certain C–C double bond.143-145 It was also reported that the 
metallacyclobutane intermediate can be stabilised by interaction of the metal centre with nearby 
donor groups of the substrate, hindering further transformation of the involved C–C double 
bond.146 
During our experimental investigation we realised that under appropriately selected 
reaction conditions, chemodiscrimination of the olefinic bonds in cross metathesis reactions is 
achievable. Reactions of some divinylated β-amino esters and a divinylated β-lactam (derived 
from ROM reactions) with methyl vinyl ketone or acrylate esters in the presence of various 
metathesis catalysts afforded monocoupled products in a chemoselective manner. The aim of 
this section is the presentation of these reactions and to explain the reasons behind their 
chemoselectivity. 
We have started our experiments with the investigation of cross metathesis reaction of 
divinyl-substituted azetidinone (±)-126 derived from norbornene β-lactam (±)-105 by ROM 
reaction (Scheme 33). This bicyclic lactam was subjected to coupling reactions with methyl 
vinyl ketone 148 or acrylic esters 47 and 145 in the presence of commercially available G1, G2, 
HG1, and HG2 catalysts. However, coupling products (±)-155 and (±)-156a,b were detected 
(by TLC monitoring) only in the presence of second generation catalysts. After trying several 
experimental conditions, the best yields were achieved by using 5 mol% HG2 catalyst in dry 
CH2Cl2 for 4 h. Monocoupled products, involving the α,β-unsaturated carbonyl part located 
near to the amide N-atom, were isolated in moderate yields (see Table 6). It is important to note 
that our attempts to increase the yields of the mono-metathesised products failed because of 
various side reactions, such as polymerisation and formation of dicoupled products. 
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Scheme 33. 
Table 6. Isolated yields for (±)-155 and (±)-156a,b in selective CM reactions with HG2 catalyst. 
Catalyst 
HG2 
Catalyst 
HG2 
Catalyst 
HG2 
Product Product Product 
 
53% 
 
51% 
 
41% 
(±)-155 (±)-156a (±)-156b 
 
Monocoupled β-lactams (±)-156a,b were considered to be suitable precursors for 
stereocontorolled access to different cispentacin derivatives with C–C double bond via opening 
of the heterocyclic ring. Thus, monocoupled cispentacin ester hydrochlorides (±)-157a,b were 
synthesised from the corresponding β-lactams (±)-156a,b by ethanolysis. Importantly, 
transesterification did not take place in the case of (±)-156a. Finally, the amino function was 
protected by benzoylation to access novel monocoupled cyclic β-amino esters (±)-158a,b 
(Scheme 33). Unfortunately, attempted ring-opening of compound (±)-155 by HCl/EtOH 
resulted in polymerisation. 
Although less known in metal-catalysed processes, we assumed in our first approach that 
hydrogen bonding interaction between the halogen atom of the Ru-alkylidene complex and the 
amide N–H moiety as hydrogen bonding donor function could force the olefin bond closer to 
the amide N-atom to participate in the coupling reaction (Fig. 8).143-145 This leads to the 
mono-metathesised product before further CM reaction could occur. 
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Figure 8. 
In further studies, we were interested in the hydrogen bonding directing effect. To verify 
our hypothesis, N-Boc-protected divinylated β-lactam (±)-160 was prepared by ROM reaction 
with G1 catalyst under ethylene atmosphere from the corresponding tricyclic compound 
(±)-159 (Scheme 34). The resulting metathesis substrate (±)-160, which cannot function as a 
hydrogen donor, was subjected to CM reaction with ethyl acrylate 47 in the presence of HG2 
catalyst. According to our expectation, when the directing effect was excluded, the coupling 
reaction was not selective and afforded a mixture of the two mono-metathesised isomers 
(±)-161 and (±)-162 in a  ratio close to 2:1 determined by the NMR analysis of the crude 
mixture. Unfortunately, our attempts to separate and isolate these two monocoupled β-lactams 
failed.  
 
Scheme 34. 
After successful chemoselective coupling of (±)-126, we have expanded the scope of the 
metathesis substrates for these reactions. β-Amino esters with 5-membered ring were used as 
our next starting compounds. First, divinyl-substitued cispentacin (±)-115 (prepared by our 
ROM method) was submitted to CM reactions with acrylic esters 47 and 145 (Scheme 35). 
However, contrary to our previous experimental results, these cross metathesis reactions of 
compound (±)-115 in view of monocoupled products were not completely selective. As 
determined by 1H-NMR analysis, a mixture of two regioisomers (±)-158 and (±)-163 was 
formed in a 4:1 ratio through a partial hydrogen bonding directing effect. 
38 
 
 
Scheme 35. 
After several failed attempts to separate the two regioisomers by column chromatography, 
the major products (±)-158a,b where the α,β-unsaturated ester part is located near to the amide 
N-atom could be successfully isolated by crystallisation from hexane/EtOAc. Their NMR data 
were completely identical with the final products shown in Scheme 33 thereby proving 
unambiguously their structure. Because of the limitations of crystallisation and metathesis side 
reactions such as the formation of dicoupled products or polymerised material, chemoselective 
coupling resulted in moderate but acceptable yields. 
After the unexpected experimental results (two isomers instead of one), we next 
investigated the chemical properties of diolefinated transpentacin (±)-117 in chemoselective 
CM reactions. For this purpose, divinylated amino ester (±)-117, where the protected amino 
group and the ester moiety are in trans relationship, was prepared by the usual ROM protocol 
(Scheme 36). 
 
Scheme 36. 
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Accordingly, compound (±)-117 was submitted to cross-coupling with acrylic esters 47 
and 145 or methyl vinyl ketone 148 at room temperature in dry CH2Cl2 with HG2 catalyst to 
afford the corresponding mono-metathesised products (±)-164a,b and (±)-165 in medium yields 
(see Table 7). In contrast with divinylated cispentacin (±)-115 [and at the same time similarly 
to divinylated β-lactam (±)-126], the CM reaction in these cases resulted in single monocoupled 
isomers. The structure of 164a was also determined by X-ray crystallography (Fig. 9). 
Table 7. Isolated yields for (±)-164a,b and (±)-165 in selective CM reactions with HG2 catalyst. 
Catalyst 
HG2 
Catalyst 
HG2 
Catalyst 
HG2 
Product Product Product 
 
47% 
 
44% 
 
50% 
(±)-164a (±)-164b (±)-165 
 
 
Figure 9. X-ray structure of compound 164a 
The results of the NH–NBoc change found previously suggested that the reason of the 
observed chemoselectivity in CM reactions is a hydrogen bond between the chlorine atom of 
the catalyst and the N–H moiety of the substrates. To further support this theory, we tried to 
disrupt this hydrogen bonding, which should decrease the selectivity. To achieve this goal, CM 
reaction between compound (±)-117 and methyl acrylate 145, which previously afforded only 
a single isomer in CH2Cl2, was performed in three additional solvents (THF, dioxane, and 
toluene). The results were in complete agreement with our expectation and showed that solvents 
capable of participating in hydrogen bonding with the substrate (dioxane, THF) compete with 
the catalyst providing a mixture of regioisomers (±)-164a and (±)-166 (approximately 2:1 ratio, 
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determined by NMR analysis of the crude product). In contrast, solvents not being able to form 
a hydrogen bond (CH2Cl2 and toluene) clearly gave only a single product (Schemes 36 and 37). 
 
Scheme 37. 
However, when another diolefinated transpentacin stereoisomer, namely (±)-118 (derived 
from diendo-norbornene β-amino ester (±)-112 by epimerisation and subsequent ROM) was 
submitted to CM reaction with α,β-unsaturated carbonyl compounds 145 and 148, inseparable 
mixtures of regioisomers (±)-167/(±)-168 and (±)-169/(±)-170, respectively, were formed. 
Regioisomeric ratios, determined by NMR analysis of the crude products, were nearly 2:1 in 
both cases (Scheme 38). 
 
Scheme 38. 
These results clearly suggested that in addition to the hydrogen bonding effect, other 
factors also influence the outcome of the coupling reactions. Chemoselectivity may originate 
from steric effects. It is also highly probable, that coordination of ruthenium to the carbonyl 
oxygen, which creates a stable 6-membered chelate ring (T1), stabilizes the metallacyclobutane 
and hinders further transformations. In the case of T2 and T3 structures, in which the vinyl 
side-chain and the ester function are trans to each other, formation of the chelate ring is less 
favored and, therefore, the cross metathesis reaction is not selective (Fig. 10). 
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Figure 10. Chelate ring stability in the case of transpentacin derivatives (±)-117, (±)-118, and (±)-115. 
Because of the importance of oxygen-containing heterocyclic β-amino acids (such as 
oxetin) we extended the scope of the chemoselective transformations with CM reactions to the 
synthesis of monocoupled O-heterocyclic counterparts. For this reason, diolefinated amino 
ester (±)-124, in which the ester and the protected amino group are in a cis arrangement, was 
prepared by ROM reaction from the corresponding bicyclic starting material (±)-122. Cross 
metathesis reaction was performed between acrylate ester 47 and compound (±)-124 in the 
presence of HG2 catalyst. Similar to its carbocyclic counterpart (±)-115, it afforded an 
inseparable mixture of (±)-171 and (±)-172 in nearly 2:1 ratio (Scheme 39).  
 
Scheme 39. 
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Finally, it seemed to be logical to prepare the trans isomer of oxygen-containing 
heterocyclic (±)-125 and subject it to CM reaction with ethyl acrylate 47 in the presence of HG2 
catalyst (Scheme 40). For this purpose, oxanorbornene amino ester (±)-122 was epimerised 
with NaOEt in EtOH at 20 °C in moderate yield to afford metathesis substrate (±)-123, which 
then underwent ROM reaction. According to our expectation (and confirming the chelate theory 
in these cases), the CM reaction led to single monocoupled product (±)-173 analogously to 
trans amino ester (±)-117. 
 
Scheme 40. 
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4. SUMMARY 
 An efficient, stereocontrolled one-step protocol has been developed for the syntheses of 
divinylated cispentacins 115, 116, 117, and 118 as well as oxacispentacin 124 and 125 
stereoisomers with multiple chiral centres from diexo-norbornene 107 and diendo-norbornene 
112 or oxanorbornene β-amino acid derivatives 122 by ROM reaction (Schemes 22 and 24). 
 During ROM reactions, the stereocentres of the starting materials were unaffected 
allowing the transfer of chiral information to the final products. ROM reactions were executed 
in the presence of commercially available Ru-based first and second generation Grubbs and 
Hoveyda-Grubbs catalysts (G1, G2, HG1, and HG2) with ethylene under argon atmosphere. 
 In the case of cispentacin derivatives 115 and 116, clear correlation between yields, the 
used catalysts and the structure of starting materials 107 and 112 was not observed, although 
HG2 catalyst was slightly more effective than the others. However, when the carboxyl and the 
amino function were in trans arrangement in starting materials 113 and 114, first generation 
catalysts G1 and HG1 gave yields more than two times higher. Lower yields found with diexo 
107 and diendo 112 derivatives may be explained by chelation of the catalyst. 
 The well-established one-step synthetic protocol was also applied for the access of 
optically pure divinylated cispentacin derivatives (+)-115 and (-)-117 from an enantiomerically 
enriched diexo-norbornene β-lactam (+)-105 obtained by enzymatic kinetic resolution of 
racemic azetidinone 105 (Scheme 23). 
 The stereocontrolled ring-opening method was applied to the preparation of a 
divinylated bicyclic β-lactam 126 and monocyclic β-lactams 131 and 136 with terminal alkene 
functions. The ROM reactions in all cases [β-lactams and (oxa)norbornene β-amino acid 
derivatives] were largely facilitated by the high ring strain of the unsaturated starting materials, 
which is released during these transformations. 
 Functionalised β-lactams 126, 131, and 136 were suitable precursors for 
stereocontrolled access of divinylated cispentacins or open-chain β-amino acid derivatives with 
anti arrangement of the carboxyl and amino moieties. Thus, these valuable olefinated β-amino 
acids 127, 132, and 137 or esters 128, 133, and 138 were prepared through the opening of the 
4-membered heterocyclic ring by aqueous or ethanolic solution of HCl (Schemes 25, 26, 
and 27). 
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 Ring-opened products containing the valuable olefin bond were further functionalised 
with α,β-unsaturated carbonyl compounds (methyl acrylate 145 or methyl vinyl ketone 148) 
through CM reaction (Schemes 29, 30, 31, and 32). The coupling reactions were executed in 
the presence of HG2 catalyst affording dicoupled azetidinones 149, 150, 151, 152, 153 and 154 
as well as dicoupled β-amino acid derivatives 146 and 147 with E geometry with moderate to 
good yields (see Tables 3, 4, and 5). 
 In the final section, olefin chemodifferentiation of divinylated products 115, 117, 118, 
124, 125, 126, and 160 (derived from ROM) through CM reactions was presented. With a 
simple modification of reaction conditions, valuable monocoupled azetidinones 155 and 
156a,b, cispentacin 158a,b, 164a,b, and 165 as well as oxacispentacin  derivatives 173 were 
the main products instead of previously described disubstituted products (Schemes 33, 35, 36, 
and 40). 
 The selectivity in the case of bicyclic β-lactam 126 originates from the hydrogen bond 
between the catalyst chlorine atom and the N–H moiety, which was confirmed by NH–NBoc 
exchange (Figure 8 and Scheme 34). However, in the case of 5-membered cyclic β-amino acid 
derivatives 115, 117, and 118, selectivity was determined by multiple factors (Schemes 35, 36, 
37, and 38). 
 Besides of secondary interactions, chelate ring stability also proved to be responsible 
for chemodifferentiation (Figure 10). This resulted in a single mono-metathesised product in 
the cases of transpentacin 117 and its oxa-analogue 125. In contrast, a mixture of regioisomers 
were formed when cispentacin 115, its oxa-analogue 124 and transpentacin 118 were used as 
starting material (Schemes 35, 36, 38, 39, and 40). The structure of 164a was also certified by 
X-ray crystallography (Figure 9). 
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